Current position:Home >Product >
L-lysine mono[[6R-[6alpha,7beta(R*)]]-7-[[amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate]
L-lysine mono[[6R-[6alpha,7beta(R*)]]-7-[[amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate](70154-78-8)
- Name: L-lysine mono[[6R-[6alpha,7beta(R*)]]-7-[[amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate]
- Synonyms:L-lysine mono[[6R-[6alpha,7beta(R*)]]-7-[[amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate]
- Molecular Formula:C22H31N5O7S
- Molecular Weight:509.57584
- CAS Registry Number:70154-78-8
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.70154-78-8 L-Lysine mono((6R-(6alpha,7beta(R*)))-7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate)
Assay:99% Transportation:By sea Application:Pharmaceutical industry
Min. Order:0
Supplier:Antimex Chemical Limied [
China (Mainland)] CAS No.70154-78-8 L-Lysine mono((6R-(6alpha,7beta(R*)))-7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate)
Assay:99% Appearance:white powder Package:drum or based on customers' requirement Storage:normal temperature storage Transportation:by sea, by air Application:We have different specifications for different applications
Min. Order:1Metric Ton
Supplier:Bluecrystal chem-union [
China (Mainland)]
Other Product
- 60239-68-1/N,N-bis(2-hydroxyethyl)undec-10-enamide
- 12045-01-1/Cobalt boride (Co2B)
- 149639-77-0/2-Butenoic acid,2-methyl-,(1R,2'R,3R,4aR,5R,6S,7R,8R,8aR)-8-(acetyloxy)-5-[(2S,3aR,6aS)-hexahydrofuro[2,3-b]furan-2-yl]hexahydro-5,6-dimethylspiro[3H-3,8a-ethano-1H-2-benzopyran-9,2'-oxirane]-1,7-diylester, (2E,2'E)- (9CI)
- 35779-40-9/1-phenyl-2-(pyridin-4-yl)ethane-1,2-dione
- 69352-91-6/Cyclopentanecarboxamide, 1-methyl- (6CI, 7CI, 9CI)
- 6196-77-6/N~2~-(4-bromophenyl)-N-tert-butyl-N~2~-(methylsulfonyl)glycinamide
- 30060-44-7/5,6-Dihydro-1-(o-ethylbenzyloxy)-2,4(1H,3H)-pyrimidinedione
- 111247-66-6/5-[(6-imino-5-methyl-3-phenyl-pyridazin-1-yl)methyl]oxazol-3-one hydro bromide
- 99615-00-6/Leucanthogenin
- 6299-79-2/4,6-bis[(2-chlorobenzyl)sulfanyl]-5-phenylpyrimidin-2-amine
- 21392-71-2/N,N-diethylaziridine-1-carboxamide
- 51112-72-2/DiisopropylTelluride
- 18069-79-9/estra-1,3,5(10)-triene-3,17beta-diol 17-butyrate
- 72906-05-9/Glycine, N-(C12-22-alkylsulfonyl) derivs., compds. with triethanolamine (1:1)
- 7740-69-4/3-ETHOXY-3-METHYL-1-BUTYNE
- 68477-21-4/Tannins, salts with N-[4-[bis[4-(dimethylamino) phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methylmethanaminium
- 783-61-9/5-phenyl-5-(trifluoromethyl)imidazolidine-2,4-dione
- 83104-76-1/1,2-dehydro-N-acetyldopamine
- 55206-69-4/2-[(2,3-epoxypropoxy)methyl]-2-(hydroxymethyl)propane-1,3-diol
- 70154-78-8/L-lysine mono[[6R-[6alpha,7beta(R*)]]-7-[[amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate]
- 29840-73-1/2-BROMO-ISONICOTINAMIDE
- 288-14-2/Isoxazole
- 9056-19-3/Prevocell
- 55243-75-9/5-phenyl-3-(piperidin-1-ylcarbonyl)-1,3-oxazolidin-2-one
- 21313-81-5/N-(4,6-diaminopyrimidin-5-yl)-2-(2-nitrophenoxy)acetamide
- 7252-58-6/[1-(4-ethoxyphenyl)ethylideneamino]urea
- 110559-84-7/1-ethyl-1-nitroso-3-(2-oxopropyl)urea
- 1649-46-3/(2alpha,5alpha,17beta)-2-fluoro-17-hydroxyandrostan-3-one
- 220168-55-8/N-(benzyloxy)-N-{[(4-nitrophenyl)carbonyl]oxy}benzamide
- 84961-86-4/Chromate(3-), (6-((4-chloro-2-hydroxy-5-methoxyphenyl)azo)-5-hydroxy-1-naphthalenesulfonato(3-))(3-hydroxy-4-((2-hydroxy-1-naphthalenyl)azo)-1-naphthalenesulfonato(3-))-, diethanolamine sodium salts